Latest news
REPL Stock Clocks Worst Day In Over 3 Months — New FDA Documents Leave Wall Street Awaiting Another Rejection For Cancer Drug - StocktwitsStocktwits · Sat, 08 Aug 2026 10:06:07 GMTWhy Did REPL, SNOW, NET Stocks Surge To 52-Week Highs Last Week? - StocktwitsStocktwits · Sat, 08 Aug 2026 09:56:28 GMTReplimune Group Inc. (REPL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS NewswireACCESS Newswire · Sat, 08 Aug 2026 04:32:16 GMTREPL Sep 2026 14.000 call (REPL260918C00014000) stock price, news, quote and history - Yahoo Finance AustraliaYahoo Finance Australia · Sat, 08 Aug 2026 02:13:38 GMTReplimune’s First Commercial Drug Arrives—With A 2027 Cash Cliff And 2030 Finish Line - TradingViewTradingView · Sat, 08 Aug 2026 00:31:00 GMTREPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law - Business WireBusiness Wire · Fri, 07 Aug 2026 21:07:00 GMTREPL Maintains Overweight Rating by JP Morgan -- Price Target Ra - GuruFocusGuruFocus · Fri, 07 Aug 2026 19:09:31 GMTRoad work: Route Z to close near Gordonville for bridge replacement - seMissourianseMissourian · Fri, 07 Aug 2026 19:08:53 GMT